Conference
Global, multicenter, open-label, randomized phase II trial comparing gemcitabine (G) with. G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer (mPC).
Authors
Wolpin BM; O'Reilly EM; Ko Y; Blaszkowsky LS; Rarick MU; Lima CMSR; Ritch PS; Chan E; Spratlin JL; Macarulla T
Volume
29
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
May 20, 2011
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X